Aspira Women's Health CFO awarded 97,417 options

The vesting schedule lists 48,708 shares for September 15, 2026, 24,354 for September 30, 2026, and 24,355 for October 15, 2026.

Rhea-AI Filing Summary

Aspira Women's Health Inc. (AWHL) Chief Financial Officer John Strahley received a direct award of 97,417 employee stock options on September 8, 2026, covering common stock. The options have a $0.30-per-share exercise price and expire September 8, 2036. The reported post-transaction position was 97,417 options. The award footnote states that 48,708 shares vested September 15, 2026, 24,354 vested September 30, 2026, and 24,355 will vest October 15, 2026.

Insider Trade Summary

Grant/Award: 97,417 shares

Grant/Award 1 txn

Insider Strahley John

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy) F1	97,417	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (Right to Buy) — 97,417 contracts (Direct)

Footnotes (1)

1. F1. 48,708 shares vested on September 15, 2026. 24,354 shares vested on September 30, 2026. 24,355 shares will vest on October 15, 2026.

Key Figures

Employee stock options awarded: 97,417 options Reported options following award: 97,417 options Exercise price: $0.30 per share +3 more

6 metrics

Employee stock options awarded 97,417 options Awarded September 8, 2026

Reported options following award 97,417 options Post-transaction position

Exercise price $0.30 per share Options covering common stock

Vested shares 48,708 shares Vested September 15, 2026

Vested shares 24,354 shares Vested September 30, 2026

Shares scheduled to vest 24,355 shares Will vest October 15, 2026

Key Terms

Employee Stock Option (Right to Buy), vested, Common Stock

3 terms

Employee Stock Option (Right to Buy) financial

"Employee Stock Option (Right to Buy)"

vested financial

"shares vested on September 15, 2026"

Common Stock financial

"underlying security: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did AWHL CFO John Strahley receive, and what are their terms?

John Strahley, Aspira Women's Health Inc.'s Chief Financial Officer, received an award of 97,417 employee stock options on September 8, 2026. The options cover common stock, have a $0.30-per-share exercise price, and expire September 8, 2036.

When do John Strahley's AWHL options vest?

The award footnote states that 48,708 shares vested on September 15, 2026, and 24,354 shares vested on September 30, 2026. Another 24,355 shares will vest on October 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 05:00 PM Accepted by SEC EDGAR 10/02/2026 - 05:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Strahley John

(Last) (First) (Middle)

C/O ASPIRA WOMEN'S HEALTH INC.

12117 BEE CAVES RD, BLDG 3-100

(Street)

AUSTIN TEXAS 78738

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aspira Women's Health Inc. [ AWHL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$0.3	09/08/2026		A		97,417		(1)	09/08/2036	Common Stock	97,417	$0	97,417	D

Explanation of Responses:

1. 48,708 shares vested on September 15, 2026. 24,354 shares vested on September 30, 2026. 24,355 shares will vest on October 15, 2026.

	/s/ John Strahley	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)